AAAAAA
Results:
1-15
|
Results: 15
Authors:
Krastev, Z
Koltchakov, V
Vladov, N
Popov, D
Milev, A
Koten, JW
Den Otter, W
Citation: Z. Krastev et al., A mesothelioma that is sensitive to locally applied IL-2, CANCER IMMU, 50(4), 2001, pp. 226-227
Authors:
De Groot, CJ
Van Luyn, MJA
Van Dijk-Wolthuis, WNE
Cadee, JA
Plantinga, JA
Den Otter, W
Hennink, WE
Citation: Cj. De Groot et al., In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts, BIOMATERIAL, 22(11), 2001, pp. 1197-1203
Authors:
Bubenik, J
Den Otter, W
Huland, E
Citation: J. Bubenik et al., Local cytokine therapy of cancer: interleukin-2, interferons and related cytokines, CANCER IMMU, 49(2), 2000, pp. 116-122
Authors:
Van Es, RJJ
Baselmans, AHC
Koten, JW
Van Dijk, JE
Koole, R
Den Otter, W
Citation: Rjj. Van Es et al., Perilesional IL-2 treatment of a VX2 head-and-neck cancer model can inducea systemic anti-tumour activity, ANTICANC R, 20(6B), 2000, pp. 4163-4170
Authors:
Koppenhagen, FJ
Balemans, LTM
Steerenberg, PA
Jagmont, TM
Den Otter, W
Storm, G
Citation: Fj. Koppenhagen et al., The design of a pharmaceutically acceptable liposomal formulation of recombinant interleukin-2 (rIL-2) for locoregional anticancer immunotherapy, J LIPOS RES, 9(3), 1999, pp. 313-329
Authors:
Den Otter, W
Cadee, J
Gavhumende, R
De Groot, CJ
Hennink, WE
Stewart, R
Citation: W. Den Otter et al., Effective cancer therapy with a single injection of interleukin-2 at the site of the tumour, CANCER IMMU, 48(7), 1999, pp. 419-420
Authors:
Fiszer-Maliszewska, L
Den Otter, W
Mordarski, M
Citation: L. Fiszer-maliszewska et al., Effect of local interleukin-2 treatment on spontaneous tumours of different immunogenic strength, CANCER IMMU, 47(6), 1999, pp. 307-314
Authors:
Bernsen, MR
Tang, JW
Everse, LA
Koten, JW
Den Otter, W
Citation: Mr. Bernsen et al., Interleukin 2 (IL-2) therapy: potential advantages of locoregional versus systemic administration, CANC TR REV, 25(2), 1999, pp. 73-82
Authors:
Den Otter, W
Root-Bernstein, R
Koten, JW
Citation: W. Den Otter et al., What is cancer? Theories on carcinogenesis, ANTICANC R, 19(6A), 1999, pp. 4601-4602
Authors:
Root-Bernstein, RS
Den Otter, W
Citation: Rs. Root-bernstein et W. Den Otter, Toward a philosophy of cancer research, ANTICANC R, 19(6A), 1999, pp. 4603-4612
Authors:
Koten, JW
Beukers, H
Den Otter, W
Citation: Jw. Koten et al., History of cancer research in nosological perspective, ANTICANC R, 19(6A), 1999, pp. 4613-4626
Authors:
Den Otter, W
Koten, JW
Citation: W. Den Otter et Jw. Koten, A 4-mutation model of carcinogenesis for tumour suppressor genes, ANTICANC R, 19(6A), 1999, pp. 4845-4852
Authors:
Den Otter, W
Citation: W. Den Otter, Evaluation: Complementarity and contradictoriness of cancer theories. A genetic perspective, ANTICANC R, 19(6A), 1999, pp. 4913-4914
Authors:
Den Otter, W
Balemans, L
Battermann, JJ
Bernsen, MR
Cadee, JA
Dobrowolski, Z
Everse, LA
Fiszer-Maliszewska, L
Gavhumende, R
De Groot, JW
De Groot, K
Hennink, WE
Hill, FWG
Jurgenliemp-Schulz, I
Klein, WR
Koten, JW
Maas, RA
Steerenberg, P
Stewart, R
Zembala, M
Citation: W. Den Otter et al., Local low-dose IL-2 therapy, HEP-GASTRO, 46, 1999, pp. 1280-1286
Authors:
Cadee, JA
De Kerf, M
De Groot, CJ
Den Otter, W
Hennink, WE
Citation: Ja. Cadee et al., Synthesis, characterization of 2-(methacryloyloxy)ethyl-(di-) L-lactate and their application in dextran-based hydrogels, POLYMER, 40(24), 1999, pp. 6877-6881
Risultati:
1-15
|